Front Row Advisors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Front Row Advisors’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-47	Closed	-$2K	–	967
2022 Q4	$2K	Sell	47 -42	-47%	-$1.66K	﹤0.01%	814
2022 Q3	$4K	Sell	89 -1	-1%	-$65	﹤0.01%	727
2022 Q2	$6K	Buy	90 +13	+17%	+$950	﹤0.01%	649
2022 Q1	$6K	Sell	77 -15	-16%	-$1.27K	﹤0.01%	694
2021 Q4	$9K	Sell	92 -7	-7%	-$672	﹤0.01%	620
2021 Q3	$9K	Hold	99	–	–	﹤0.01%	605
2021 Q2	$9K	Hold	99	–	–	﹤0.01%	607
2021 Q1	$8K	Sell	99 -9	-8%	-$679	﹤0.01%	611
2020 Q4	$7K	Buy	108 +25	+30%	+$1.56K	﹤0.01%	624
2020 Q3	$6K	Buy	83 +12	+17%	+$715	﹤0.01%	662
2020 Q2	$4K	Buy	+71	New	+$3.82K	﹤0.01%	725

Other funds holding SYNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Front Row Advisors's SYNH Position: Q1 2023 in Review

Front Row Advisors sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2023, closing a stake of 47 shares — an estimated $2K sold.

Front Row Advisors first reported a position in SYNH in Q2 2020 and held it in 11 quarters. The position peaked at $9K in Q4 2021. 305 funds tracked by Wall St. Rank hold SYNH as of Q1 2023.

Front Row Advisors reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
Front Row Advisors sold 47 Syneos Health, Inc. Class A Common Stock shares in Q1 2023, an estimated $2K.
Front Row Advisors first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2020 and held it in 11 quarters.
Front Row Advisors's Syneos Health, Inc. Class A Common Stock position peaked at $9K in Q4 2021.
305 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2023.

Based on Front Row Advisors's 13F filing for Q1 2023, filed 15 May 2023.